NeuroMolecular Pharmaceuticals' Series C Round

NeuroMolecular Pharmaceuticals raised a round of funding on August 22, 2006. Investors include Mohr Davidow Ventures.

NeuroMolecular Pharmaceuticals is developing and commercializing superior neuroprotective medicines for the treatment of central nervous system (CNS) disorders. The Company has built a robust pipeline…

Articles about NeuroMolecular Pharmaceuticals' Series C Round: